Investigative Site — New York, New York

Investigative Site is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Investigative Site has participated in 15 clinical trials with 4 currently active.

Therapeutic areas: Hereditary Hemochromatosis, Tumor Hyperinsulinism (Tumor HI), Menorrhagia.

Sponsors: La Jolla Pharmaceutical Company, Rezolute, Ferring Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Site?

Investigative Site has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Site conducted?

Investigative Site has 15 clinical trials on record, with 4 currently active. Their work covers Hereditary Hemochromatosis, Tumor Hyperinsulinism (Tumor HI), Menorrhagia.

Is Investigative Site accredited by Crixeo Health?

Yes — Investigative Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.